Bridging Lab to Patient with Brian Wamhoff | Charlottesville News
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Bridging Lab to Patient with Brian Wamhoff | Charlottesville News
-
ナレーター：
-
著者：
Brian Wamhoff, a rare biotech leader with hands-on experience from lab to patient, has been tapped as the first chief strategy and business officer for the new Manning Institute of Biotechnology at UVA — a bold move to bridge the gap between scientific discovery and real medicine. With a mission to accelerate treatments and close the “translational valley of death,” Wamhoff will connect the institute with investors, partners, and agencies to turn breakthroughs into bedside solutions faster — even as a $27 million state funding cut forces the team to find new financial pathways. The institute, set to open in late 2027, is racing to deliver life-saving drugs to patients who are waiting.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/417df0033d6a3448